Yolk-shell CoFe2O4@hollow mesoporous carbon spheres for Levofloxacin hydrochloride removal: Synergy enhancement effect of adsorption and degradation
Abstract
A yolk-shell structured magnetic composite catalyst with hollow mesoporous carbon spheres as the shell and CoFe2O4 nanoparticles as the core (CoFe2O4@HMCS) was successfully designed and synthesized for peroxymonosulfate (PMS) activation to degrade levofloxacin hydrochloride (LFX). Hollow mesoporous carbon spheres (HMCS) possess tunable hollow mesoporous structures, serving as both an excellent adsorbent and catalyst. However, its adsorptive function in catalytic degradation processes has been easily ignored. This work highlights the remarkable adsorption capacity of CoFe2O4@HMCS (qe = 404.32 mg g-1). During the synergistic process of adsorption and degradation, LFX can be rapidly and efficiently enriched by CoFe2O4@HMCS, achieving 93.42 % removal within 60 min through subsequent synergistic degradation. The HMCS can stabilize CoFe2O4 under complex reaction conditions, reducing Co/Fe leaching. Simultaneously, the combination of HMCS and CoFe2O4 also endows HMCS with magnetic properties, which further enhances the catalytic performance of the composite material. Furthermore, a dual-pathway mechanism for PMS activation was proposed, demonstrating that both radical (SO4-• and •OH) and nonradical (direct electron transfer) pathways cooperatively contributed to LFX degradation through PMS activation, with the direct electron transfer mechanism playing a dominant role. Meanwhile, the potential transformation pathways of LFX were elucidated. This research aims to develop a…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.